estrogen receptor positive

estrogen receptor positive

Oncology Breast CA cells with a receptor to which estrogens can attach; this is associated with an improved prognosis as the CA usually responds to antiestrogen therapy that blocks the receptors. See Estrogen receptor.
References in periodicals archive ?
Lineage-Restricted Mammary Stem Cells Sustain the Development, Homeostasis, and Regeneration of the Estrogen Receptor Positive Lineage," Cell Reports, 2017; 20 (7): 1525 DOI: 10.
Objective: To compare the Argyrophilic nucleolar organizer regions size and dispersion in estrogen receptor positive and ER-ve tumors of invasive ductal carcinoma of breast.
Estrogen Receptor Positive (ER+) Breast Cancer - Pipeline Insights, 2016 Report envisage Pipeline Intelligence by identifying the key players along with their potential pipeline molecule.
Estrogen receptor positive breast cancer cells have proteins that attract the hormones estrogen and/or progesterone as they float by in the blood.
According to the researchers, young women who are current or recent smokers and had been smoking a pack a day for at least 10 years, had a 60 percent increased risk of estrogen receptor positive breast cancer.
found 60 percent increased risk of developing one of the most common types of breast cancer called estrogen receptor positive, in young women who smoked a pack of cigarettes daily, for more than ten years.
This study highlights BCL-2, a gene whose expression is known to have significance in estrogen receptor positive breast cancer.
Some women cannot tolerate estrogen deprivation, but for those with estrogen receptor positive breast tumors, anastrazole significantly improves survival.
Aromasin is a prescription medicine for the adjuvant treatment of postmenopausal women with estrogen receptor positive early breast cancer.
In estrogen receptor positive disease, the late recurrences keep coming; you keep on getting them in years 5-9, 10-14, and 15-plus," he said.
While we do not have a chemoprevention strategy that directly targets the estrogen receptor-negative tumors of importance to high-risk patients, a reduction in estrogen receptor positive tumors still is of value.

Full browser ?